SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-20-004176
Filing Date
2020-04-23
Accepted
2020-04-23 07:01:23
Documents
5
Period of Report
2020-06-04
Effectiveness Date
2020-04-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20200604xdef14a.htm DEF 14A 500649
2 GRAPHIC tmb-20200604xdef14a001.jpg GRAPHIC 3620
3 GRAPHIC tmb-20200604xdef14a010.jpg GRAPHIC 74323
4 GRAPHIC tmb-20200604xdef14a011.jpg GRAPHIC 73273
5 GRAPHIC tmb-20200604xdef14a009.jpg GRAPHIC 4542
  Complete submission text file 0001558370-20-004176.txt   716751
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37581 | Film No.: 20809162
SIC: 2834 Pharmaceutical Preparations